Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

NCT03077659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma of the Prostate

Interventions

DRUG: NanoPac®

Sponsor

NanOlogy, LLC

Collaborators

[object Object]